Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Huma
| Project | A digital first, population-level, early detection, engagement and self-management programme for people who are undiagnosed and/or high-risk of developing modifiable Cardiovascular Disease (CVD) |
|---|---|
| Description |
Huma’s remote patient monitoring (RPM) platform connects patients and clinical teams through smartphone-based technology. Huma’s primary care arm – iPlato – are experts in enhancing patient access and engagement through technology. For this project, Huma and iPlato’s technologies will proactively engage and support people who are identified by their GPs as being high-risk of undiagnosed CVD. |
| Funding | £ 493,877 |
| Competition | Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases |
| Competition Date | June 2022 |
| Categories | Cardiovascular |
| Health Innovation Network Partner | UCL Partners |
| Website | https://www.huma.com |
Cardisio GmbH
| Project | Assessing the impact of using community-based heart testing to detect early signs of Cardiovascular Disease through a novel, quick, low-cost screener which uses sophisticated AI-based analysis |
|---|---|
| Description |
The Cardisio test is a quick 1st line triage test, measuring a patient’s electrical heart activity in 3-dimensions, and is taken at rest in a primary care setting. Test results in 3 disease areas (CAD, arrythmia, Structural heart disease) are made available to the physician in c.4 minutes. |
| Funding | £ 342,484 |
| Competition | Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases |
| Competition Date | June 2022 |
| Categories | Cardiovascular |
| Health Innovation Network Partner | Health Innovation East |
| Website | https://www.cardis.io |
Inavya Ventures Ltd
| Project | Post-Operative 60 Days |
|---|---|
| Description |
Avatr is an AI platform that lets doctors input care and medication plans and removes complexity making it easy for patients to follow. During the PoP-60 study, the clinical and economic benefits of Avatr will be evaluated for cardiac patients discharged from hospital. |
| Funding | £ 180,564 |
| Competition | Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases |
| Competition Date | June 2022 |
| Categories | Cardiovascular |
| Health Innovation Network Partner | Imperial College Health Partners |
| Website | https://www.avatr.ai |